Exelixis Inc. Common Stock vs Veeva Systems — how do they compare? Exelixis Inc. Common Stock trades at $58.58 (market cap $14.48B), while Veeva Systems trades at $285.41 (market cap $45.74B). The key difference: Veeva Systems is far larger — about 3.2× Exelixis Inc. Common Stock's market cap, and Exelixis Inc. Common Stock is more actively traded (2,374,774 versus 1,118,315). Which is the better fit depends on your goals — on Pluang, investors hold Exelixis Inc. Common Stock for 0 Days and Veeva Systems for 5 Days on average.
| EXEL | VEEV | |
|---|---|---|
Market Cap | $14.48B | $45.74B |
Volume | 2,374,774 | 1,118,315 |
Sector | Health | Technology |
52-Week High | $59.13 | $299.10 |
52-Week Low | $34.54 | $151.43 |
Typical Hold Time | 0 Days | 5 Days |
Enterprise Value | $13.81B | $38.65B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →Veeva Systems provides cloud software, data, and services for the life sciences industry. Its applications support functions across clinical research, regulatory operations, quality, safety, and commercial teams.
Read more on VEEV →